Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added new MedlinePlus Genetics topic: Head and neck squamous cell carcinoma, expanding the page’s coverage of genetic information on a high-interest medical condition.
    Difference
    0.5%
    Check dated 2025-10-19T16:24:12.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added a government-funding status notice and version v3.2.0; removed a MedlinePlus Genetics topic on head and neck squamous cell carcinoma (and updated from v3.1.0 to v3.2.0).
    Difference
    5%
    Check dated 2025-10-05T09:28:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Update adds broader terminology and a new genetics-related topic, and bumps the revision from v3.0.2 to v3.1.0.
    Difference
    0.7%
    Check dated 2025-09-28T03:09:09.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Removed the MedlinePlus Genetics topic for Head and neck squamous cell carcinoma. This narrows the genetics-related content available on that topic.
    Difference
    0.5%
    Check dated 2025-09-20T22:01:40.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic for head and neck squamous cell carcinoma and updated the page to v3.0.2; removed the 'Back to Top' link.
    Difference
    0.8%
    Check dated 2025-09-13T16:51:29.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-06T14:12:41.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.